NCT01986283View on ClinicalTrials.gov

Abuse Potential Study of PF-00345439

PHASE1CompletedINTERVENTIONAL

Enrollment

67

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Opioid Users

Interventions

DRUG

Capsule

Taken once

DRUG

PF-00345439

40 mg capsule swallowed whole, taken once

DRUG

PF-00345439

40 mg capsule chewed, taken once

DRUG

oxycodone

40 mg solution, taken once

Trial Locations (1)

84106

Lifetree Clinical Research, Salt Lake City

Sponsors

Lead Sponsor

Pain Therapeutics

All Listed Sponsors

lead

Pain Therapeutics

INDUSTRY